| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.00034 | 1 |